Direct evidence for two distinct prosomatostatin converting enzymes. Detection using a rapid, sensitive, and specific assay for propeptide converting enzymes.

R. Mackin,B. D. Noe

DOI: https://doi.org/10.1016/s0021-9258(18)48261-0

IF: 5.485

1987-05-15

Journal of Biological Chemistry

Abstract:

What problem does this paper attempt to address?

Comparison of Race-Based and Non-Race-Based Glomerular Filtration Rate Equations for the Assessment of Renal Functional Risk Before Nephrectomy

Maria B Antony,Nikhil Gopal,Zachary Kozel,Sandeep Gurram,W Marston Linehan,Mark W Ball

DOI: https://doi.org/10.1016/j.urology.2022.11.032

IF: 2.633

Urology

Abstract:Objective: To compare the performance of race-based and race-neutral estimated glomerular filtration rate (eGFR) calculators in patients undergoing kidney surgery. Methods: Analysis of institutional kidneys surgeries from 2006-2021 was conducted. Demographics, serum creatinine (SCr), protein dipstick, and creatinine clearance (CrCl) were assessed within 1 week prior to surgery. SCr was used to calculate eGFR using 3 models: Modification of Diet in Renal Disease (MDRD), Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI 2009), and CKD-EPI 2021. Patients were classified based on Kidney Disease: Improving Global Outcomes (KDIGO) criteria for CKD staging and prognosis, with urine CrCl treated as benchmark for analysis. Receiver operating characteristic (ROC) analysis evaluated accuracy of eGFR calculators' binary discrimination of eGFR less than 60 mL/min. CKD stage agreement between eGFR and urine CrCl was assessed. Results: A total of 554 kidney surgeries in 336 patients had necessary laboratory data for analysis. The cohort was 62% male, with a median age of 47. Within this cohort, 8.1% (n=45) were Black, and 80% (n=441) were White. glomerular filtration rate (GFR) from 24-hour urine CrCl normalized by BSA did not vary significantly from eGFR by SCr based calculators. The proportion of patients with eGFR <60 significantly differed when using Modification of Diet in Renal Disease, CKD-EPI 2009, and CKD-EPI 2021 equations when compared to CrCl (P<.001). Still, they performed equivalently in the staging of CKD, as well as in predicting GFR of less than 60, and classifying CKD prognosis of "moderately increased or higher". Conclusion: A race-neutral eGFR calculator can perform equivalently to established eGFR calculators, with the added benefit of mitigating biases that account for racial disparities in nephrectomy decision making.
Lubrication of animal joints. I. The arthrotripsometer.

F. C. Linn

DOI: https://doi.org/10.2106/00004623-196749060-00005

1967-09-01

Abstract:The arthrotripsometer is an apparatus for sensing and recording the instantaneous frictional properties and deformations of articular cartilage in vitro under conditions simulating human locomotion. The frictional force measurements would have been straightforward were it not that the center of rotation of the twenty-one canine ankles studied varied throughout each oscillation. Folding of the friction-force curves about the end points of oscillation served to determine the instantaneous center of rotation and coefficient of friction. The center of rotation was determined as the mid-point between the two curves in the central portion of travel and extrapolated to the trailing end of each oscillation. At the start of each half cycle of oscillation, there occurred an abrupt transition and then a slower buildup of the coefficient of friction. These end effects are attributed to both shearing and small compressive deformations (plowing) of the articular cartilage. The plowing component of sliding friction decreased with increasing speed. The coefficient of friction decreased with increasing load. The friction was much lower in joints than in metallic or rubber bearings. When immersed in physiological saline solution, the mean sliding coefficient of friction of the ankles was .0124 (fifty-seven tests); whereas, bovine synovial fluid reduced this value by an additional 54 per cent to µ = .0057 (nineteen tests). The recovery of articular cartilage from compressive deformation was much quicker when the joint was oscillated than when it was stationary.
Race-modified estimated glomerular filtration rate underestimates chronic kidney disease prevalence in Black patients undergoing partial and radical nephrectomy: Implications for surgical planning

Hunter L. Hasley,Teona Iarajuli,Jennifer Nguyen,Daniel Thiemann,Martin Malik,Jacquelyn Roth,Michael Raver,Michael Stifelman,Ravi Munver,Mutahar Ahmed,Nitin Yerram

DOI: https://doi.org/10.4103/ua.ua_7_24

2024-07-01

Urology Annals

Abstract:Introduction: In estimated glomerular filtration rate equations (eGFR), the race multiplier (RM) yields greater eGFR values and may assign less severe chronic kidney disease (CKD) stages to black individuals. When deciding on appropriateness for partial nephrectomy (PN), patients with CKD are often considered a relative or absolute indication. We hypothesize that the eGFR RM may have ramifications for patients being counseled for radical nephrectomy (RN) versus PN to manage their renal tumor. Methods: We utilized prospective and retrospective, IRB-approved single-center databases to select patients who underwent PN or RN between 2016 and 2022. Demographics, preoperative risk factors, preoperative eGFR, and surgical management were collected. Descriptive statistics and two-tailed difference of proportion tests compared the percentage of patients with CKD who underwent nephrectomy. Results: This cohort included 1137 patients who underwent RN or PN, including 74 (6.5%) Black patients and 93.5% ( n = 1063) non-Black patients. There was no statistically significant difference between the eGFR of Black and non-Black individuals using the Modification of Diet in Renal Disease equation ( P = 0.24) or Chronic Kidney Disease Epidemiology Collaboration 2009 (CKD-EPI 2009) ( P = 0.45); however, there was statistically significant difference in eGFR between sample populations when using CKD-EPI 2021 ( P = 0.0055). Of the Black patient cohort, 16.2% of patients reclassified to a worse CKD class using CKD-EPI 2021, including 9.5% of Black patients reclassified to CKD3a or worse, and 14.6% of all patients (Black and non-Black) reclassified to a different CKD class under the CKD-EPI 2021 equation. Conclusions: There are quantitative differences in the evaluation of eGFR when utilizing different equations that may impact clinical considerations and health equity outcomes for nephrectomy across racial groups.
Use of skin conductance changes during mental stress testing as an index of autonomic arousal in cardiovascular research.

S. Jacobs,S. Jacobs,R. Friedman,R. Friedman,R. Friedman,J. Parker,G. Tofler,G. Tofler,A. H. Jimenez,J. Muller,J. Muller,H. Benson,H. Benson,P. Stone,P. Stone

DOI: https://doi.org/10.1016/0002-8703(94)90748-X

IF: 5.099

1994-12-01

American Heart Journal

Abstract:
Dear Milt.

M. Harris

Abstract:
Impact of chronic kidney disease on in-hospital outcomes following left ventricular assist device placement: A national perspective

Rajkumar Doshi,Mohamed Taha,Sailaja Pisipati,Krunalkumar Patel,Jaafar Al-Khafaji,Rupak Desai,Jay Shah,Nageshwara Gullapalli

DOI: https://doi.org/10.1016/j.hrtlng.2019.05.013

Abstract:Background: Left ventricular assist devices (LVADs) are being increasingly utilized for the treatment of stage-D heart failure. A LVAD is a battery-operated, mechanical pump that assists in pumping blood out of the left ventricle (LV) into the aorta, thereby lowering left ventricular burden. Prevalence of chronic kidney disease (CKD) is increasing in patients receiving LVAD. Objectives: The purpose of this study was to compare in-hospital mortality and hospitalization expenditure associated with CKD in patients receiving LVAD implantation. Methods: Using the National Inpatient Sample from January 2012 through September 2015, index hospitalizations for LVAD were identified. Based on kidney function, LVAD recipients were divided into three groups: Group 1 included patients with normal renal function or CKD stages I-III. Groups 2 and 3 comprised of patients with CKD stage IV/V, and end-stage renal disease on dialysis respectively. Results: A total of 20,656 patients received LVAD during the study period. Mean age was 56.1 years; 76.8% were men. In a fully adjusted model, in-hospital mortality was higher in group 2 (OR: 1.33, CI: 1.16-1.50) and highest in group 3 (OR: 8.95, CI: 6.90-11.61). Similarly, the length of hospitalization, and hospitalization cost were higher in group 2 and highest in group 3. Conclusion: Despite improving outcomes in patients receiving LVAD, CKD remained a significant health problem. Worsening in-hospital outcomes paralleling the degree of kidney dysfunction were observed in patients receiving LVADs in this study.
Kidney Failure Risk Equation in vascular access planning: a population-based study supporting value in decision making

Mohammad Atiquzzaman,Bingyue Zhu,Alexandra Romann,Lee Er,Ognjenka Djurdjev,Micheli Bevilacqua,Michelle M Y Wong,Peter Birks,Tae Won Yi,Anurag Singh,Navdeep Tangri,Adeera Levin

DOI: https://doi.org/10.1093/ckj/sfae008

2024-01-11

Clinical Kidney Journal

Abstract:ABSTRACT Background The Kidney Failure Risk Equation (KFRE) can play a better role in vascular access (VA) planning in patients with chronic kidney disease (CKD) requiring hemodialysis (HD). We described the VA creation and utilization pattern under existing estimated glomerular filtration rate (eGFR)-based referral, and investigated the utility of KFRE score as an adjunct variable in VA planning. Methods Patients with CKD aged ≥18 years with eGFR <20 mL/min/1.73 m2 who chose HD as dialysis modality from January 2010 to August 2020 were included from a population-based database in British Columbia, Canada. Modality selection date was the index date. Exposures were categorized as (i) current eGFR-based referral, (ii) eGFR-based referral plus KRFE 2-year risk score on index date (KFRE-2) >40% and (iii) eGFR-based referral plus KFRE-2 ≤40%. We estimated the proportion of patients who started HD on arteriovenous fistula/graft (AVF/G) within 2 years, indicating timely pre-emptive creation, and the proportion of patients in whom AVF/G was created but did not start HD within 2 years, indicating too-early creation. Results Study included 2581 patients, median age 71 years, 60% male. Overall, 1562(61%) started HD and 276 (11%) experienced death before HD initiation within 2 years. Compared with current referral, the proportion of patients who started HD on AVF/G was significantly higher when KFRE-2 was considered in addition to current referral (49% vs 58%, P-value <.001). Adjunct KFRE-2 significantly reduced too-early creation (31% vs 18%, P-value <.001). Conclusions KFRE in addition to existing eGFR-based referral for VA creation has the potential to improve VA resource utilization by ensuring more patients start HD on AVF/G and may minimize too-early/unnecessary creation. Prospective research is necessary to validate these findings.

urology & nephrology
Enhancing Vascular Access Planning in CKD: Validating the 40% KFRE Threshold for predicting ESKD in a French Retrospective Cohort Study

Maxime Ingwiller,Nicolas Keller,Thierry Krummel,Eric Prinz,Lydie Steinmetz,Thierry Hannedouche,Nans Florens

DOI: https://doi.org/10.1093/ckj/sfae220

2024-07-13

Clinical Kidney Journal

Abstract:Abstract Background Establishing the optimal timing for creating vascular access in patients with chronic kidney disease (CKD) is a critical and challenging aspect of patient management. The Kidney Disease: Improving Global Outcomes (KDIGO) guidelines propose using a 40% 2-year threshold based on the Kidney Failure Risk Equation (KFRE) for this purpose. However, the effectiveness of this threshold compared to traditional methods, such as estimated Glomerular Filtration Rate (eGFR), is not well-established. Methods In this monocentric retrospective cohort study, we analyzed data from patients referred for vascular mapping before arteriovenous fistula (AVF) creation between April 2013 and June 2023. The study aimed to compare the ≥ 40% 2-year KFRE threshold with a <15 mL/min/m273 eGFR threshold for predicting End Stage Kidney Disease (ESKD). We assessed the probability of ESKD, considering death before AVF creation as a competing risk. Discrimination between KFRE and eGFR was evaluated using C-statistics. Results The study included 238 patients with a mean age of 65.2 years and a mean eGFR of 13.3 mL/min/m273. Over a median follow-up of 10.7 months, 178 patients developed ESKD, and 21 died before ESKD. Probability of ESKD at 1 year was 77.6% (95% CI, 69.9-85.3%) using a ≥ 40% 4 variables KFRE threshold versus 65.8% (95% CI, 58.3-73.3%) using a <15 mL/min/m273 eGFR threshold. The C-statistics indicated better predictive ability for the 8-variable KFRE at 6 months (0.82 (95% CI: 0.76-0.88)),while both 4 and 8-variable KFRE models were effective for 1-year predictions (0.835 (95% CI :0.78-0.89) and 0.82 (95% CI : 0.76-0.875) respectively). Sensitivity and specificity analyses favored the ≥ 40% KFRE threshold over the eGFR threshold. Conclusions This study suggests that using a ≥ 40% 2-year KFRE threshold for planning vascular access in CKD patients is promising and potentially superior to the traditional <15 mL/min/m273 eGFR threshold. This approach may offer a balance between minimizing premature AVF creation and the risk of starting dialysis via a central venous catheter.

urology & nephrology
Eligibility for pharmacological therapies in heart failure with reduced ejection fraction: implications of the new Chronic Kidney Disease Epidemiology Collaboration creatinine equation for estimating glomerular filtration rate

Jawad H. Butt,Carly Adamson,Kieran F. Docherty,Muthiah Vaduganathan,Scott D. Solomon,Inder S. Anand,Faiez Zannad,Lars Køber,Pardeep S. Jhund,John J.V. McMurray

DOI: https://doi.org/10.1002/ejhf.2460

2022-03-08

European Journal of Heart Failure

Abstract:AIMS: The new Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation for estimating glomerular filtration rate (eGFR), based on serum creatinine, that does not incorporate race may reclassify individuals, irrespective of race, from one eGFR category to another, with implications for eligibility for treatments in patients with heart failure and reduced ejection fraction (HFrEF).METHODS AND RESULTS: A total of 43 138 ambulatory patients with HFrEF from 12 clinical trials were included (mean age 64.3 years; 9580 [22.2%] women). Mean eGFR was 67 (standard deviation [SD] 21) ml/min/1.73 m2 and 70 (SD 21) ml/min/1.73 m2 using the original and new CKD-EPI equations, respectively (mean difference 3.20 ml/min/1.73 m2 , 95% confidence interval [CI] 3.17-3.23, p < 0.001). Of the 935 patients with chronic kidney disease (CKD) stages 4 or 5, identified using the original equation, 309 (33.0%) were reclassified to CKD stages 1-3 (eGFR ≥30 ml/min/1.73 m2 ) with the new equation. However, the opposite was observed among the 2521 Black patients (5.8%) included, with a reduction in mean eGFR from 75 to 68 ml/min/1.73 m2 using the original and new equations, respectively (mean difference 6.94 ml/min/1.73 m2 , [95% CI 6.82-7.06], p < 0.001). The number of Black patients with an eGFR <30 ml/min/1.73 m2 increased from 49 (1.9%) using the original equation to 71 (2.8%) with the new equation.CONCLUSIONS: The new CKD-EPI creatinine equation reclassified CKD stage in a large proportion of patients with HFrEF enrolled in clinical trials. As eGFR is an essential determinant of eligibility for several key pharmacological therapies in HFrEF, this reclassification could result in a substantial change in the proportion of patients considered eligible for such therapies and reduce the proportion of eligible Black patients.

cardiac & cardiovascular systems
Cystatin C- Versus Creatinine-Based Assessment of Renal Function and Prediction of Early Outcomes Among Patients With a Left Ventricular Assist Device

Alberto Pinsino,Giulio M. Mondellini,Eugene A. Royzman,Katherine L. Hoffman,Debra D'Angelo,Melissa Mabasa,Antonia Gaudig,Amelia M. Zuver,Amirali Masoumi,A. Reshad Garan,Sumit Mohan,Syed A. Husain,Katherine Toma,Robert T. Faillace,Jon T. Giles,Koji Takeda,Hiroo Takayama,Yoshifumi Naka,Veli K. Topkara,Ryan T. Demmer,Jai Radhakrishnan,Paolo C. Colombo,Melana Yuzefpolskaya

DOI: https://doi.org/10.1161/CIRCHEARTFAILURE.119.006326

2020-01-22

Abstract:Estimated glomerular filtration rate (eGFR) based on serum creatinine (sCr) improves early after left ventricular assist device (LVAD) implantation but subsequently declines. Although sCr is a commonly accepted clinical standard, cystatin C (CysC) has shown superiority in assessment of renal function in disease states characterized by muscle wasting. Among patients with an LVAD, we aimed to (1) longitudinally compare CysC-eGFR and sCr-eGFR, (2) assess their predictive value for early postoperative outcomes, and (3) investigate mechanisms which might explain potential discrepancies. A prospective cohort (n=116) with CysC and sCr concurrently measured at serial time points, and a retrospective cohort (n=91) with chest computed tomography performed within 40 days post-LVAD were studied. In the prospective cohort, the primary end point was a composite of in-hospital mortality, renal replacement therapy, or severe right ventricular failure. In the retrospective cohort, muscle mass was estimated using pectoralis muscle area indexed to body surface area (pectoralis muscle index). In the prospective cohort, sCr-eGFR significantly improved early post-LVAD and subsequently declined, whereas CysC-eGFR remained stable. CysC-eGFR but not sCr-eGFR predicted the primary end point: odds ratio per 5 mL/(min·1.73 m 2 ) decrease 1.16 (1.02–1.31) versus 0.99 (0.94–1.05). In retrospective cohort, for every 5 days post-LVAD, a 6% decrease in pectoralis muscle index was observed (95% CI, 2%–9%, P =0.003). After adjusting for time on LVAD, for every 1 cm 2 /m 2 decrease in pectoralis muscle index, there was a 4% decrease in 30-day post-LVAD sCr (95% CI, 1%–6%, P =0.004). Initial improvement in sCr-eGFR is likely due to muscle wasting following LVAD surgery. CysC may improve assessment of renal function and prediction of early postoperative outcomes in patients with an LVAD.
Impact of Race‐Adjusted Glomerular Filtration Rate Estimation on Eligibility for Simultaneous Liver‐Kidney Transplantation

Sarjukumar Panchal,Marina Serper,Therese Bittermann,Sumeet K. Asrani,David S. Goldberg,Nadim Mahmud

DOI: https://doi.org/10.1002/lt.26310

2021-10-21

Liver Transplantation

Abstract:BackgroundEstimated glomerular filtration rate (eGFR) is adjusted for Black race in commonly used formulas. This has potential implications for access to simultaneous liver-kidney transplant (SLKT), as qualifying criteria rely on eGFR. MethodsWe performed a retrospective study of United Network for Organ Sharing (UNOS) national transplant registry data between 2/28/2002 and 3/31/2019 to evaluate the proportion of Black patients who would be reclassified as meeting SLKT criteria (as defined per current policies) if race adjustment were removed from two prominent eGFR equations (MDRD-4 and CKD-EPI). ResultsOf the 7,937 Black patients listed for transplant during the study period, we found that 3.6% would have been reclassified as qualifying for chronic kidney disease (CKD)-related SLKT with removal of race adjustment for MDRD-4, and 3.0% for CKD-EPI; this represented 23.7% and 18.7% increases in SLKT candidacy, respectively. Reclassification impacted women more than men (e.g. 4.5% vs. 3.0% by MDRD-4, p<0.05). In an exploratory analysis, patients meeting SLKT criteria by race unadjusted eGFR equations were significantly more likely to receive liver transplantation alone (LTA) as compared to SLKT. Approximately 2% of reclassified patients required kidney transplantation within one year of LTA, versus 0.3% of non-reclassified patients. DiscussionIn conclusion, race adjustment in eGFR equations may impact SLKT candidacy for 3-4% of Black patients listed for LTA overall. Approximately 2% of patients reclassified as meeting SLKT criteria require short-term post-LTA kidney transplantation. These data argue for developing novel algorithms for GFR estimation free of race to promote equity.

gastroenterology & hepatology,surgery,transplantation
[Lymphography with oily contrast media. Complications and contra-indications (author's transl)].

P. Schneider,G. Goeckenjan,R. Jungblut

1976-10-01

Der Radiologe

Abstract:Following lymphography pulmonary fat microembolization is regularly found. It is accompanied by hemodynamic pulmonary changes as well as by impairment of respiratory lung function and respiratory metabolism. The risks of complications and several contra-indications are described. To avoid complications explicit precautions are recommended.
Left Ventricular Assist Device and the Kidney: Getting to the Heart of the Matter

Mayanka Kamboj,Amir Kazory

DOI: https://doi.org/10.1159/000502080

Abstract:Left ventricular assist devices (LVADs) are increasingly used for the management of patients with advanced heart failure (AHF) due to their established salutary impact on hemodynamic status and survival benefit. Impairment in kidney function is common in the setting of AHF and is associated with adverse impact on the outcomes. Cardiorenal interactions represent a complex pattern in these patients rendering their care a challenge that needs to be addressed by multidisciplinary approaches. Following LVAD implantation, AHF patients have the potential to achieve marked improvement in kidney function due to increased cardiac output and kidney perfusion as well as reduction in renal venous congestion. However, a subset of these patients is also at risk for acute kidney injury and resurgence of kidney dysfunction on continued mechanical circulatory support. Herein, we provide an overview of various aspects of changes in kidney function pre- and post-LVAD implantation, review potential underlying pathophysiologic mechanisms, and the impact on the outcomes. Moreover, the currently available data on renal replacement therapy of LVAD-treated patients, whether in the acute setting or as a maintenance therapy, are discussed in detail along with areas of high clinical relevance where a clear gap in knowledge exists.
Creation and Validation of a Novel Sex-Specific Mortality Risk Score in LVAD Recipients

Aditi Nayak,Yingtian Hu,Yi-An Ko,Rebecca Steinberg,Subrat Das,Anurag Mehta,Chang Liu,John Pennington,Rongbing Xie,James K Kirklin,Robert L Kormos,Jennifer Cowger,Marc A Simon,Alanna A Morris

DOI: https://doi.org/10.1161/JAHA.120.020019

2021-04-06

Abstract:Background Prior studies have shown that women have worse 3-month survival after receiving a left ventricular assist device compared with men. Currently used prognostic scores, including the Heartmate II Risk Score, do not account for the increased residual risk in women. We used the IMACS (International Society for Heart and Lung Transplantation Mechanically Assisted Circulatory Support) registry to create and validate a sex-specific risk score for early mortality in left ventricular assist device recipients. Methods and Results Adult patients with a continuous-flow LVAD from the IMACS registry were randomly divided into a derivation cohort (DC; n=9113; 21% female) and a validation cohort (VC; n=6074; 21% female). The IMACS Risk Score was developed in the DC to predict 3-month mortality, from preoperative candidate predictors selected using the Akaike information criterion, or significant sex × variable interaction. In the DC, age, cardiogenic shock at implantation, body mass index, blood urea nitrogen, bilirubin, hemoglobin, albumin, platelet count, left ventricular end-diastolic diameter, tricuspid regurgitation, dialysis, and major infection before implantation were retained as significant predictors of 3-month mortality. There was significant ischemic heart failure × sex and platelet count × sex interaction. For each quartile increase in IMACS risk score, men (odds ratio [OR], 1.86; 95% CI, 1.74-2.00; P<0.0001), and women (OR, 1.93; 95% CI, 1.47-2.59; P<0.0001) had higher odds of 3-month mortality. The IMACS risk score represented a significant improvement over Heartmate II Risk Score (IMACS risk score area under the receiver operating characteristic curve: men: DC, 0.71; 95% CI, 0.69-0.73; VC, 0.69; 95% CI, 0.66-0.72; women: DC, 0.73; 95% CI, 0.70-0.77; VC, 0.71 [95% CI, 0.66-0.76; P<0.01 for improvement in receiver operating characteristic) and provided excellent risk calibration in both sexes. Removal of sex-specific interaction terms resulted in significant loss of model fit. Conclusions A sex-specific risk score provides excellent risk prediction in LVAD recipients.
Predictive Effect of Renal Function on Clinical Outcomes in Older Adults With Acute Myocardial Infarction: Results From an Observational Cohort Study in China

Hui Gao,Hui Peng,Aidong Shen,Hui Chen,Hongwei Li

DOI: https://doi.org/10.3389/fcvm.2021.772774

IF: 3.6

2021-12-06

Frontiers in Cardiovascular Medicine

Abstract:Background: The impact of estimated glomerular filtration rate (eGFR) on the risk of death and cardiovascular events in individuals with acute myocardial infarction (AMI) is less well established, particularly in the old Chinese population. The aim of this study was to investigate the association of eGFR with clinical outcomes among older subjects with AMI. We further developed a nomogram for the prediction of 1- and 3-year survival in this population. Methods: A cohort of 2,366 AMI subjects aged over 60 years in 2013–2020 were enrolled in the Cardiovascular Center of Beijing Friendship Hospital Database (CBD) Bank. Outcomes including cardiovascular (CV) death, all-cause death, non-fatal myocardial infarction (MI), non-fatal stroke, revascularization, and cardiac rehospitalization were collected overall and by eGFR category at baseline. eGFR was estimated by the Chronic Kidney Disease Epidemiology Collaboration equation (CKD-EPI). Subjects were categorized into four groups according to quartiles of eGFR: ≤ 63.02, 63.03–78.45, 78.46–91.50, >91.51 ml/min/1.73 m 2 . Hazard ratios (HRs), corresponding 95% confidence intervals (CIs) as well as the nomogram were assessed using Cox regression models. Validation of the nomogram was estimated by discrimination and calibration. Results: Incidence rates and multivariable-adjusted hazard ratios of CV and all-cause death decreased significantly across quartiles of eGFR over a median follow-up time of 36.7 months. In adjusted analysis, compared with eGFR ≤ 63.02 ml/min/1.73 m 2 , patients with eGFR of 63.03–78.45, 78.46–91.50, >91.51 ml/min/1.73 m 2 experienced decreased risks of CV death [respective HRs of 0.58 (95% CI, 0.38–0.90), 0.61 (95% CI, 0.38–0.99), and 0.48 (95% CI, 0.25–0.90); all p < 0.05] and all-cause death [respective HRs of 0.64 (95% CI, 0.47–0.88), 0.61 (95% CI, 0.42–0.88), and 0.54 (95% CI, 0.35–0.84); all p < 0.05]. Age, eGFR quartiles, BMI, glycated hemoglobin, LVEF, LM/multi-vessel disease, angiotensin-converting enzyme inhibitors (ACEIs), or angiotensin receptor blockers (ARBs) prescribed at discharge were associated with all-cause death. The developed model predicted 1- and 3-year probability of survival, which performed well in both discrimination and calibration. Conclusion: In older patients with AMI, early identification of eGFR reduced and cardiovascular risks management may prevent poor clinical outcomes.

cardiac & cardiovascular systems
Association between pre-heart transplant kidney function and post-transplant outcomes in Black and White adults

Ying Wei,Elizabeth Mostofsky,Francisco J. Barrera,Lathan Liou,Soziema Salia,Martha Pavlakis,Murray A. Mittleman

DOI: https://doi.org/10.1007/s40620-024-02077-5

IF: 4.4061

2024-09-13

Journal of Nephrology

Abstract:It remains unknown whether estimated glomerular filtration rate (eGFR) using the refit Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation without a term for race is associated with mortality and the need for kidney replacement therapy (KRT) differentially between Black and White heart transplant recipients.

urology & nephrology
Asthma and atopy – the price of affluence?

L. V. Hertzen,T. Haahtela

DOI: https://doi.org/10.1046/j.1398-9995.2003.00433.x

2004-02-01

Abstract:Irrespective of improved knowledge of many aspects of atopic diseases, the unfavorable trends in their prevalence particularly among children could not have been reversed. A growing body of evidence suggests that something may lack from our societal affluence that has the capacity to provide protection against the development of atopic diseases. Much attention during the last years has been devoted to the hygiene hypothesis. This review outlines the impact of environment and lifestyle, particularly from the perspective of the East–West gradient, on the development of atopic diseases, with a special emphasis on the hygiene hypothesis in its broadest sense.
Clinical impact of the Kidney Failure Risk Equation for vascular access planning

Ulrika Hahn Lundström,Chava L Ramspek,Friedo W Dekker,Merel van Diepen,Juan Jesus Carrero,Ulf Hedin,Marie Evans

DOI: https://doi.org/10.1093/ndt/gfae064

IF: 7.1857

2024-03-14

Nephrology Dialysis Transplantation

Abstract:Abstract Background Risk-based thresholds for arteriovenous (AV) access creation has been proposed to aid vascular access planning. We aimed to assess the clinical impact of implementing the kidney failure risk equation (KFRE) for vascular access referral. Methods 16,102 nephrology-referred chronic kidney disease (CKD) patients from the Swedish Renal Registry 2008-2018 were included. The KFRE was calculated repeatedly, and the timing was identified for when the KFRE risk exceeded several pre-defined thresholds and/or the estimated glomerular filtration rate <15 ml/min/1.73m2 (eGFR15). To assess the utility of the KFRE/eGFR thresholds, cumulative incidence curves of kidney replacement therapy (KRT) or death, and decision-curve analyses were computed at 6, 12 months, and 2 years. The potential impact of using the different thresholds was illustrated by an example from the Swedish access registry. Results The 12-month specificity for KRT initiation was highest for KFRE>50% 94.5 (95% Confidence interval [CI] 94.3–94.7), followed by KFRE>40% 90.0 (95% CI 89.7–90.3), while sensitivity was highest for KFRE>30% 79.3 (95% CI 78.2–80.3) and eGFR<15 ml/min/1.73m2 81.2 (95% CI 80.2–82.2). The 2-year positive predictive value was 71.5 (95% CI 70.2–72.8), 61.7 (95% CI 60.4–63.0) and 47.2 (95% CI 46.1–48.3) for KFRE>50%, KFRE>40%, and eGFR<15 respectively. Decision curve analyses suggested the largest net benefit for KFRE>40% over two years and KFRE>50% over 12 months when it is important to avoid the harm of possibly unnecessary surgery. In Sweden, 54% of nephrology-referred patients started hemodialysis in a central venous catheter (CVC) of which only 5% had AV access surgery >6 months before initiation. 60% of the CVC patients exceeded KFRE>40% a median of 0.8 years (interquartile range 0.4-1.5) before KRT initiation. Conclusions The utility of using KFRE>40% and KFRE>50% is higher compared to the more traditionally used eGFR threshold <15 ml/min/1.73m2 for vascular access planning.

urology & nephrology,transplantation
Liquid chromatography/tandem mass spectrometry method for quantitative estimation of polyethylene glycol 400 and its applications.

V. Vijaya Bhaskar,A. Middha,S. Tiwari,S. Shivakumar

DOI: https://doi.org/10.1016/j.jchromb.2013.02.021

2013-05-01

Abstract:
Comparison of three creatinine-based equations to predict adverse outcome in a cardiovascular high-risk cohort: an investigation using the SPRINT research materials

Insa E Emrich,John W Pickering,Felix Götzinger,Rafael Kramann,Michael Kunz,Lucas Lauder,Vasilios Papademetriou,Michael Böhm,Gunnar H Heine,Felix Mahfoud

DOI: https://doi.org/10.1093/ckj/sfae011

2024-01-19

Clinical Kidney Journal

Abstract:ABSTRACT Background Novel creatinine-based equations have recently been proposed but their predictive performance for cardiovascular outcomes in participants at high cardiovascular risk in comparison to the established CKD-EPI 2009 equation is unknown. Method In 9361 participants from the United States included in the randomized controlled SPRINT trial, we calculated baseline estimated glomerular filtration rate (eGFR) using the CKD-EPI 2009, CKD-EPI 2021, and EKFC equations and compared their predictive value of cardiovascular events. The statistical metric used is the net reclassification improvement (NRI) presented separately for those with and those without events. Results During a mean follow-up of 3.1 ± 0.9 years, the primary endpoint occurred in 559 participants (6.0%). When using the CKD-EPI 2009, the CKD-EPI 2021, and the EKFC equations, the prevalence of CKD (eGFR <60 ml/min/1.73 m2 or >60 ml/min/1.73 m2 with an ACR ≥30 mg/g) was 37% vs. 35.3% (P = 0.02) vs. 46.4% (P < 0.001), respectively. The corresponding mean eGFR was 72.5 ± 20.1 ml/min/1.73 m2 vs. 73.2 ± 19.4 ml/min/1.73 m2 (P < 0.001) vs. 64.6 ± 17.4 ml/min/1.73 m2 (P < 0.001). Neither reclassification according to the CKD-EPI 2021 equation [CKD-EPI 2021 vs. CKD-EPI 2009: NRIevents: −9.5% (95% confidence interval (CI) −13.0% to −5.9%); NRInonevents: 4.8% (95% CI 3.9% to 5.7%)], nor reclassification according to the EKFC equation allowed better prediction of cardiovascular events compared to the CKD-EPI 2009 equation (EKFC vs. CKD-EPI 2009: NRIevents: 31.2% (95% CI 27.5% to 35.0%); NRInonevents: −31.1% (95% CI −32.1% to −30.1%)). Conclusion Substituting the CKD-EPI 2009 with the CKD-EPI 2021 or the EKFC equation for calculation of eGFR in participants with high cardiovascular risk without diabetes changed the prevalence of CKD but was not associated with improved risk prediction of cardiovascular events for both those with and without the event.

urology & nephrology

Direct evidence for two distinct prosomatostatin converting enzymes. Detection using a rapid, sensitive, and specific assay for propeptide converting enzymes.

Comparison of Race-Based and Non-Race-Based Glomerular Filtration Rate Equations for the Assessment of Renal Functional Risk Before Nephrectomy

Lubrication of animal joints. I. The arthrotripsometer.

Race-modified estimated glomerular filtration rate underestimates chronic kidney disease prevalence in Black patients undergoing partial and radical nephrectomy: Implications for surgical planning

Use of skin conductance changes during mental stress testing as an index of autonomic arousal in cardiovascular research.

Dear Milt.

Impact of chronic kidney disease on in-hospital outcomes following left ventricular assist device placement: A national perspective

Kidney Failure Risk Equation in vascular access planning: a population-based study supporting value in decision making

Enhancing Vascular Access Planning in CKD: Validating the 40% KFRE Threshold for predicting ESKD in a French Retrospective Cohort Study

Eligibility for pharmacological therapies in heart failure with reduced ejection fraction: implications of the new Chronic Kidney Disease Epidemiology Collaboration creatinine equation for estimating glomerular filtration rate

Cystatin C- Versus Creatinine-Based Assessment of Renal Function and Prediction of Early Outcomes Among Patients With a Left Ventricular Assist Device

Impact of Race‐Adjusted Glomerular Filtration Rate Estimation on Eligibility for Simultaneous Liver‐Kidney Transplantation

[Lymphography with oily contrast media. Complications and contra-indications (author's transl)].

Left Ventricular Assist Device and the Kidney: Getting to the Heart of the Matter

Creation and Validation of a Novel Sex-Specific Mortality Risk Score in LVAD Recipients

Predictive Effect of Renal Function on Clinical Outcomes in Older Adults With Acute Myocardial Infarction: Results From an Observational Cohort Study in China

Association between pre-heart transplant kidney function and post-transplant outcomes in Black and White adults

Asthma and atopy – the price of affluence?

Clinical impact of the Kidney Failure Risk Equation for vascular access planning

Liquid chromatography/tandem mass spectrometry method for quantitative estimation of polyethylene glycol 400 and its applications.

Comparison of three creatinine-based equations to predict adverse outcome in a cardiovascular high-risk cohort: an investigation using the SPRINT research materials